Active specific immunotherapy of human solid tumors.
A limited study of tumor patients with otherwise untreatable lesions suggests the feasibility of using enzyme altered cells in the active specific immunotherapy of human solid tumors.
D000230:Adenocarcinoma / Q000628:therapy; D001943:Breast Neoplasms / Q000628:therapy; D003110:Colonic Neoplasms / Q000628:therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D008207:Lymphatic Metastasis / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy